Indication

Acute Myeloid Leukemia With Variant MLL Translocations

1 clinical trial

4 products

4 drugs

Clinical trial
Personalized NK Cell Therapy in CBT
Status: Recruiting, Estimated PCD: 2025-05-31
Product
Busulfan